Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g)
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
MONET1-MOtesanib NSCLC Efficacy and Tolerability Study
- Status
- TERMINATED
- Phase
- PHASE3
Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
Gemcitabine + Carboplatin in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2